Regulation 2 Amendment of regulation 3 of the Branded Health Service Medicines (Costs) Regulations 2018
(1)
Regulation 3 (Payment scheme) of The Branded Health Service Medicines (Costs) Regulations 2018f1 is amended as follows.
(2)
In paragraph (1), for the table substitute—
“Table
Applicable Period Payment Percentage 1st April 2023 to the end of 2023 27.5% 2024 and any subsequent calendar year 27.5% ”.
(3)
In paragraph (1B)—
(a)
for “1st July 2022 to the end of 2022” substitute “1st April 2023 to the end of 2023”,
(b)
for “17.7%” substitute “28.6%”, and
(c)
for “14.3%” substitute “27.5%”.
(4)
In paragraph (1C)—
(a)
for “1st July 2022 to the end of 2022” substitute “1st April 2023 to the end of 2023”,
(b)
in sub-paragraph (a)—
(i)
for “1st January 2022” substitute “1st January 2023”, and
(ii)
for “30th June 2022” substitute “31st March 2023”, and
(c)
in sub-paragraph (b), for “10.9%” substitute “24.4%”.
Annotations
Footnotes
- f1
-
S.I 2018/345; relevant amending instruments are S.I. 2018/1255, S.I. 2020/258 and S.I. 2022/593.